1. Home
  2. NMRA vs GSRT Comparison

NMRA vs GSRT Comparison

Compare NMRA & GSRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • GSRT
  • Stock Information
  • Founded
  • NMRA 2019
  • GSRT 2023
  • Country
  • NMRA United States
  • GSRT United States
  • Employees
  • NMRA N/A
  • GSRT N/A
  • Industry
  • NMRA
  • GSRT
  • Sector
  • NMRA
  • GSRT
  • Exchange
  • NMRA Nasdaq
  • GSRT Nasdaq
  • Market Cap
  • NMRA 268.5M
  • GSRT 302.5M
  • IPO Year
  • NMRA 2023
  • GSRT 2024
  • Fundamental
  • Price
  • NMRA $1.62
  • GSRT $10.38
  • Analyst Decision
  • NMRA Buy
  • GSRT Strong Buy
  • Analyst Count
  • NMRA 8
  • GSRT 1
  • Target Price
  • NMRA $7.14
  • GSRT $19.00
  • AVG Volume (30 Days)
  • NMRA 383.3K
  • GSRT 345.4K
  • Earning Date
  • NMRA 11-11-2025
  • GSRT 01-01-0001
  • Dividend Yield
  • NMRA N/A
  • GSRT N/A
  • EPS Growth
  • NMRA N/A
  • GSRT N/A
  • EPS
  • NMRA N/A
  • GSRT 0.19
  • Revenue
  • NMRA N/A
  • GSRT N/A
  • Revenue This Year
  • NMRA N/A
  • GSRT N/A
  • Revenue Next Year
  • NMRA N/A
  • GSRT N/A
  • P/E Ratio
  • NMRA N/A
  • GSRT $53.50
  • Revenue Growth
  • NMRA N/A
  • GSRT N/A
  • 52 Week Low
  • NMRA $0.61
  • GSRT $9.86
  • 52 Week High
  • NMRA $17.19
  • GSRT $11.49
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 47.71
  • GSRT 43.96
  • Support Level
  • NMRA $1.60
  • GSRT $10.35
  • Resistance Level
  • NMRA $1.70
  • GSRT $10.43
  • Average True Range (ATR)
  • NMRA 0.09
  • GSRT 0.05
  • MACD
  • NMRA -0.01
  • GSRT 0.02
  • Stochastic Oscillator
  • NMRA 8.51
  • GSRT 37.50

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About GSRT GSR III Acquisition Corp. Ordinary Shares

GSR III Acquisition Corp is a blank check company.

Share on Social Networks: